Maximum Dose of Slenyto Melatonin Micro Tablet
The maximum dose of Slenyto (melatonin prolonged-release micro-tablet) is 10 mg per night.
Dosing Information
Based on the available evidence, while the provided studies primarily discuss melatonin prolonged-release formulations at 2 mg doses 1, 2, 3, 4, 5, 6, the specific product Slenyto has a higher maximum approved dose. The evidence shows:
Standard Dosing Pattern
- Starting dose: Typically 2 mg taken 1-2 hours before bedtime
- Dose escalation: Can be increased based on response
- Maximum dose: 10 mg per night for Slenyto specifically
Important Clinical Context
The bulk of clinical trial evidence supports 2 mg prolonged-release melatonin as the most studied dose in adults ≥55 years with primary insomnia 3, 5, 6. This dose has demonstrated:
- Significant improvements in sleep quality and morning alertness
- Reduction in sleep onset latency by approximately 24 minutes 5
- Excellent safety profile with no withdrawal symptoms or tolerance 4, 6
However, dose-response meta-analysis suggests that efficacy peaks at 4 mg/day 7, indicating that higher doses may provide additional benefit for some patients.
Key Clinical Considerations
Timing Optimization
- Administer 3 hours before desired bedtime for optimal efficacy (not the commonly used 30 minutes) 7
- This earlier timing significantly improves sleep onset latency reduction
Safety Profile
- Prolonged-release melatonin shows excellent tolerability even with long-term use (6-12 months) 4
- No evidence of dependence, tolerance, or rebound insomnia upon discontinuation 3, 6
- Most common side effects at standard doses include drowsiness (28.8%) and headache (25.1%) 8
Population-Specific Notes
- Primary evidence base is for adults ≥55 years with primary insomnia
- Slenyto's higher maximum dose (10 mg) allows for dose titration in patients who don't respond adequately to lower doses
- The 2 mg dose remains the most evidence-supported starting point
Clinical Pearl: While 10 mg is the maximum approved dose, most patients achieve therapeutic benefit at 2-4 mg. Start low and titrate based on response, as higher doses don't necessarily provide proportionally greater benefit and may increase side effects.